| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 91.11 | 50.75 | 60.34 | 41.58 |
Depreciation | -22.28 | -22.06 | -19.89 | -19.17 |
Tax paid | -30.15 | -18.06 | -19.89 | -5.96 |
Working capital | 60.27 | 35.89 | 36.48 | -52.78 |
Other operating items | ||||
Operating | 98.95 | 46.51 | 57.03 | -36.34 |
Capital expenditure | 198.03 | 42.43 | 8.7 | -123.45 |
Free cash flow | 296.98 | 88.94 | 65.74 | -159.79 |
Equity raised | 717.75 | 618.91 | 508.47 | 506.14 |
Investing | 0 | 0 | 8.02 | 15.71 |
Financing | 109.47 | 13.34 | -0.6 | -46.43 |
Dividends paid | 0 | 0 | 2.11 | 1.69 |
Net in cash | 1,124.2 | 721.19 | 583.75 | 317.32 |
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
